Health Secretary Robert F. Kennedy Jr. has officially added two rare and severe diseases, Duchenne muscular dystrophy and metachromatic leukodystrophy (MLD), to the federal recommendations for newborn screening. This decision marks a significant shift in public health policy aimed at enhancing early detection and intervention for these conditions.
The announcement follows a controversial period during which the Health and Human Services department, under Kennedy’s leadership, disbanded the expert committee responsible for reviewing new diseases for inclusion in screening protocols. This move disrupted ongoing efforts that had been in place for years to include both Duchenne and MLD in the screening recommendations, raising concerns among advocates and healthcare professionals.
By incorporating these diseases into the Recommended Uniform Screening Panel (RUSP), the federal government is empowering states to adopt these guidelines, which could lead to earlier diagnoses and treatment options for affected newborns. While some states have already begun screening for Duchenne, this federal endorsement is expected to encourage broader adoption and ultimately improve patient outcomes.
Get started today with Solo access →
